Related Experiment Video
Updated: Aug 10, 2026

11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Immune responses to osteochondral allografts. Current knowledge and future directions
Clinical Orthopaedics and Related Research
|April 1, 1983
Summary
Immune responses to osteochondral allografts can be reduced by processing methods like deep-freezing or freeze-drying. Further research is needed to understand the impact of immunogenicity on graft success in reconstructive surgery.
Area of Science:
- Immunology
- Orthopedic Surgery
- Transplantation Science
Background:
- Immune responses against osteochondral allografts are observed in animal models and human recipients.
- Cell-surface antigens on skeletal tissues are primary sensitizers.
- Processing methods significantly impact allograft immunogenicity.
Purpose of the Study:
- To review the immunogenicity of osteochondral allografts.
- To explore the role of cell-surface antigens and matrix components in immune sensitization.
- To discuss the implications of immunogenicity for future research in reconstructive joint surgery.
Main Methods:
- Literature review of studies on osteochondral allograft immunogenicity.
- Analysis of immune responses in various animal models and human recipients.
- Evaluation of processing techniques (deep-freezing, freeze-drying) on immunogenicity.
Main Results:
- Deep-freezing and freeze-drying reduce the immunogenicity of osteochondral allografts.
- Histocompatibility antigens are major contributors to immune responses.
- Matrix components like proteoglycans and collagen may also act as immunogens, though their significance is under investigation.
Conclusions:
- Processing techniques can mitigate immune responses to osteochondral allografts.
- The relative importance of immunogenicity versus biomechanical factors in graft incorporation requires further study.
- Understanding immune responses is crucial for advancing osteochondral allograft research and clinical success.

